Difference between revisions of "Vascular sarcoma"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - "==[https://www.nccn.org/ NCCN]==" to "==NCCN==")
m (Text replacement - "http://www.esmo.org/" to "https://www.esmo.org/")
 
Line 15: Line 15:
 
=Guidelines=
 
=Guidelines=
 
'''Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.'''
 
'''Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.'''
==[http://www.esmo.org/ ESMO]==
+
==[https://www.esmo.org/ ESMO]==
 
*[https://www.sciencedirect.com/science/article/pii/S0923753419340876?via%3Dihub Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2014)] [https://pubmed.ncbi.nlm.nih.gov/25210080/ PubMed]
 
*[https://www.sciencedirect.com/science/article/pii/S0923753419340876?via%3Dihub Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2014)] [https://pubmed.ncbi.nlm.nih.gov/25210080/ PubMed]
  

Latest revision as of 17:44, 23 June 2024

Section editor
Elizabethdavis2.jpg
Elizabeth J. Davis, MD
Vanderbilt University
Nashville, TN, USA
0 regimens on this page
0 variants on this page

Note: this page does not contain any regimens. The following links will take you to disease-specific pages with regimens:


Guidelines

Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.

ESMO

NCCN

Hemangioendothelioma, all lines of therapy

Hemangiopericytoma (solitary fibrous tumor), all lines of therapy